- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 401/06 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Patent holdings for IPC class C07D 401/06
Total number of patents in this class: 4715
10-year publication summary
|
395
|
311
|
343
|
399
|
338
|
301
|
279
|
309
|
219
|
148
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2709 |
96 |
| Janssen Pharmaceutica N.V. | 3383 |
92 |
| Merck Sharp & Dohme LLC | 3741 |
78 |
| Bristol-myers Squibb Company | 4893 |
71 |
| F. Hoffmann-La Roche AG | 7921 |
71 |
| Boehringer Ingelheim International GmbH | 4648 |
71 |
| Novartis AG | 10850 |
65 |
| VALO Health, Inc. | 172 |
53 |
| Merck Patent GmbH | 5823 |
40 |
| The Regents of the University of California | 19929 |
37 |
| Eli Lilly and Company | 3844 |
37 |
| Syngenta Crop Protection AG | 6061 |
35 |
| Allergan, Inc. | 2346 |
34 |
| AstraZeneca AB | 2908 |
33 |
| Centre National de La Recherche Scientifique | 10432 |
33 |
| Mycovia Pharmaceuticals, Inc. | 41 |
33 |
| Toray Industries, Inc. | 6945 |
32 |
| ChemoCentryx, Inc. | 385 |
32 |
| Astellas Pharma Inc. | 1092 |
30 |
| Hoffmann-La Roche Inc. | 3422 |
29 |
| Other owners | 3713 |